Announce Date | 06/05/2025 |
EPS Normalized Actual | $0.42 (Miss by $-0.098) |
EPS GAAP Actual | $0.42 (Miss by $-0.098) |
Revenue Actual | $1.12588B |
Revenue Surprise | Beat by $1125.88M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Nov 2027 | 4.14369 | 19.1 | 3.79434 | 4.43971 | 3 |
Oct 2027 | 4.01 | 19.74 | 3.95904 | 4.08359 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 0.06 | 0.06 | 1.12588B | 19.1% | 1125.88M |
FQ1 2025 (Feb 2025) | 0.31 | 0.31 | 1.07226B | 3.22% | 1072.26M |
FQ4 2024 (Nov 2024) | 0 | 0 | 1.12411B | -0.48% | 1124.11M |
FQ3 2024 (Jul 2024) | 0.0986 | 0.0986 | 0.942308B | -13.33% | 942.31M |
FQ2 2024 (Apr 2024) | -0.12 | -0.12 | 0.910826B | -24.35% | 910.83M |
FQ1 2024 (Jan 2024) | 0.34 | 0.34 | 1.03771B | -1.81% | 1037.71M |
FQ4 2023 (Oct 2023) | 0.62 | 0.62 | 1.12949B | 14.03% | 1129.49M |
FQ3 2023 (Jul 2023) | 0.2 | 0.2 | 1.06789B | 18.72% | 1067.89M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.20912 | -- | 1.15284 | 1.25438 | 5 |
FQ3 2027 (Jul 2027) | 1.0052 | -- | 0.95841 | 1.04283 | 4 |
FQ2 2027 (Apr 2027) | 0.86998 | -- | 0.82949 | 0.90255 | 4 |
FQ1 2027 (Jan 2027) | 0.78075 | -- | 0.74441 | 0.80998 | 7 |
FQ4 2026 (Oct 2026) | 1.10595 | -- | 1.10595 | 1.10595 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.35B | -- | 1.3B | 1.39B | 4 |
FQ3 2027 (Jul 2027) | 1.25B | -- | 1.21B | 1.29B | 6 |
FQ2 2027 (Apr 2027) | 1.2B | -- | 1.16B | 1.24B | 4 |
FQ1 2027 (Jan 2027) | 1.18B | -- | 1.14B | 1.21B | 6 |
FQ4 2026 (Oct 2026) | 1.25B | -- | 1.25B | 1.25B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.06 | 0.06 | 100% | |
FQ1 2025 (Feb 2025) | 0.31 | 0.31 | 100% | |
FQ4 2024 (Nov 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Jul 2024) | 0.0986 | 0.0986 | 100% | |
FQ2 2024 (Apr 2024) | -0.12 | -0.12 | 100% | |
FQ1 2024 (Jan 2024) | 0.34 | 0.34 | 100% | |
FQ4 2023 (Oct 2023) | 0.62 | 0.62 | 100% | |
FQ3 2023 (Jul 2023) | 0.2 | 0.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $1.13B | $1125.88M | 100% |
FQ1 2025 (Feb 2025) | $0B | $1.07B | $1072.26M | 100% |
FQ4 2024 (Nov 2024) | $0B | $1.12B | $1124.11M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.94B | $942.31M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.91B | $910.83M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.04B | $1037.71M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.13B | $1129.49M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.07B | $1067.89M | 100% |